Literature DB >> 11825771

Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages.

Filomena M Perrella Balestieri1, Allan R Pires Queiroz, Cristoforo Scavone, Vlaudia M Assis Costa, Manoel Barral-Netto, Ises de Almeida Abrahamsohn.   

Abstract

Inhibition of lipopolysaccharide (LPS)-induced nitric oxide (NO) production was demonstrated in J774-G8 macrophages infected with Leishmania (L.) amazonensis promastigotes. The downmodulation of NO production observed in infected and LPS-stimulated J774-G8 cells correlated with a reduction in inducible nitric oxide synthase (iNOS) activity. Reduction in iNOS activity was not paralleled by decreased iNOS mRNA expression, suggesting that the parasite affects post-transcriptional events of NO synthesis. Supplementation with L-arginine or tetrahydrobiopterin did not increase NO production, suggesting that inhibition is not due to an insufficiency of substrate or co-factor. Treatment with anti-IL-10, anti-IL-4 or anti-TGF-beta neutralizing antibodies also failed to increase NO production, indicating that these cytokines are not involved in the observed parasite-induced inhibition of NO synthesis. However, treatment of the cultures with IFN-gamma resulted in a marked increase in NO production by infected LPS-stimulated cells. These results show that although L.(L.) amazonensis infection inhibits iNOS activity and NO production by J774-G8 cells, activation by IFN-gamma is capable of overriding the suppression of NO synthesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825771     DOI: 10.1016/s1286-4579(01)01505-2

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  28 in total

1.  Antiprotozoan activity of Brazilian marine cnidarian extracts and of a modified steroid from the octocoral Carijoa riisei.

Authors:  Juliana Quero Reimão; Alvaro Esteves Migotto; Miriam H Kossuga; Roberto G S Berlinck; André Gustavo Tempone
Journal:  Parasitol Res       Date:  2008-09-02       Impact factor: 2.289

2.  Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200.

Authors:  Mauro Cortez; Chau Huynh; Maria Cecilia Fernandes; Kathleen A Kennedy; Alan Aderem; Norma W Andrews
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

3.  Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.

Authors:  C Ricardo-Carter; M Favila; R E Polando; R N Cotton; K Bogard Horner; D Condon; W Ballhorn; J P Whitcomb; M Yadav; R L Geister; J S Schorey; M A McDowell
Journal:  Parasite Immunol       Date:  2013-12       Impact factor: 2.280

4.  Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody.

Authors:  María Colmenares; Stephanie L Constant; Peter E Kima; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection.

Authors:  René E Vasquez; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

Review 6.  Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens.

Authors:  Carolina Prolo; María Noel Alvarez; Rafael Radi
Journal:  Biofactors       Date:  2013-11-26       Impact factor: 6.113

Review 7.  Leishmania interferes with host cell signaling to devise a survival strategy.

Authors:  Suvercha Bhardwaj; Neetu Srivastava; Raki Sudan; Bhaskar Saha
Journal:  J Biomed Biotechnol       Date:  2010-04-08

8.  In vitro infectivity of species of Leishmania (Viannia) responsible for American cutaneous leishmaniasis.

Authors:  Marliane Batista Campos; Cláudia Maria De Castro Gomes; Adelson Alcimar Almeida de Souza; Ralph Lainson; Carlos Eduardo Pereira Corbett; Fernando Tobias Silveira
Journal:  Parasitol Res       Date:  2008-06-05       Impact factor: 2.289

9.  Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis.

Authors:  Ariane de Jesus Sousa-Batista; Wallace Pacienza-Lima; Natalia Arruda-Costa; Camila Alves Bandeira Falcão; Maria Ines Ré; Bartira Rossi-Bergmann
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

10.  Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives.

Authors:  Luiz Antônio Dutra; Letícia de Almeida; Thais G Passalacqua; Juliana Santana Reis; Fabio A E Torres; Isabel Martinez; Rosangela Gonçalves Peccinini; Chung Man Chin; Konstantin Chegaev; Stefano Guglielmo; Roberta Fruttero; Marcia A S Graminha; Jean Leandro dos Santos
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.